Home BioStable Science & Engineering

BioStable Science & Engineering

BioStable Science & Engineering Announces U.S. Pilot Launch and First Commercial Use of the HAART 300 Aortic Annuloplasty Device

June 14, 2017 BioStable Science & Engineering, Inc. announced today the first commercial uses of the HAART 300 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown,...

BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device

Joe Cunningham, BioStable board member and Managing Director of lead investor Santé Ventures, added, “We are very grateful for the cooperation between the BioStable management team and FDA.